QLGN: The configuration of the Crypto Assets accomplice account has been completed, and the purchase of the first batch of CXC 10 strategic assets will start this week.

MarsBitNews

2025-10-13 04:19:20

BNB-2,57%

ETH-4,41%

SOL-4,17%

According to Mars Finance, Nasdaq-listed company Qualigen Therapeutics (QLGN) announced that it has completed the establishment of infrastructure such as USD cash settlement, bank accounts, and crypto asset custody accounts over the past two weeks, and will officially begin purchasing its first batch of strategic assets this week, primarily investing in the top 10 crypto assets by market capitalization, focusing on “blue chip” crypto assets including BNB, ETH, and SOL. Previously, it was reported that FF has made a strategic investment of $41 million in Nasdaq-listed company QLGN, and Jia Yueting invested $4 million, with QLGN set to be renamed CXC 10.

View Original

Disclaimer: The information on this page may come from third parties and does not represent the views or opinions of Gate. The content displayed on this page is for reference only and does not constitute any financial, investment, or legal advice. Gate does not guarantee the accuracy or completeness of the information and shall not be liable for any losses arising from the use of this information. Virtual asset investments carry high risks and are subject to significant price volatility. You may lose all of your invested principal. Please fully understand the relevant risks and make prudent decisions based on your own financial situation and risk tolerance. For details, please refer to Disclaimer.

Comment

0/400

No comments